SEC Form 4 · accession 0001209191-15-063939
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mostafa Kamal
Officer — CEO, Magellan Rx Management
Period of report
Aug 3, 2015
Accepted (ET)
Aug 5, 2015 · 12:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $60.55 | Aug 3, 2015 | A | 50,000 | A | — | Aug 3, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Options vest and become exercisable in one third increments on August 3 of each of 2016, 2017 and 2018, subject to satisfaction of certain performance requirements.
- F2Not applicable.